dc.date.accessioned |
2018-06-04T16:38:50Z |
|
dc.date.available |
2018-06-04T16:38:50Z |
|
dc.date.issued |
2018-05-25 |
|
dc.identifier.uri |
http://dspace.ncl.res.in:8080/xmlui/handle/20.500.12252/3917 |
|
dc.description |
Scientists from National Chemical Laboratory and the International Centre for Genetic Engineering and Biotechnology (ICGEB) have achieved a potential breakthrough in anti-malarial research.
Three research groups, each led by NCL’s D Srinivasa Reddy and Dhanasekaran Shanmugam, and Amit Sharma of ICGEB, have identified fungal-metabolite molecules as a potential anti-malarial drug. |
en_US |
dc.language.iso |
en |
en_US |
dc.publisher |
Times of India |
|
dc.subject |
Anti-Malarial Drug |
en_US |
dc.subject |
Advanced Malaria Medication |
en_US |
dc.subject |
Cladosporin Molecule |
en_US |
dc.subject |
Aspergillus Flavus |
en_US |
dc.title |
Scientists find potential leads to develop new anti-malarial drugs |
en_US |
dc.title.alternative |
Medication for Malaria |
en_US |
dc.type |
Newspaper Article |
en_US |
local.division.division |
Organic Chemistry Division |
en_US |
dc.description.university |
|
en_US |